| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0011860> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0020616> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0081937> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C0935929> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C1447020> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C1827106> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C2936720> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33249199_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Division of Diabetes, Nutrition and Metabolic Disorders, CHU Liège, Liège, Belgium; Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), Liège University, Liège, Belgium. Electronic address: andre.scheen@chuliege.be.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Scheen_Andr%C3%A9_J>
?:doi	S1262-3636(20)30178-610.1016/j.diabet.2020.11.005
?:doi	<https://research.tib.eu/covid-19/entity/S1262-3636%2820%2930178-610.1016/j.diabet.2020.11.005>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Diabetes & metabolism
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33249199>
?:pmid	<https://research.tib.eu/covid-19/entity/33249199>
?:pmid	33249199
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0011847_PROCESS_OF_C0030705>
?:title	DPP-4 inhibition and COVID-19: From initial concerns to recent expectations.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33249199>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33249199>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all